Strata Critical Medical (SRTA) awards 30,913 RSUs to board director
Rhea-AI Filing Summary
PHILIP EDWARD M reported acquisition or exercise transactions in this Form 4 filing.
Strata Critical Medical, Inc. director Philip Edward M received a grant of 30,913 shares of Class A common stock on July 30, 2026, in the form of Restricted Stock Units. The RSUs will be settled in common shares and 100% vest on the date of the company’s 2027 Annual Meeting of Stockholders. Following this equity award, he holds 265,078 shares directly.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 30,913 shares
Net Buy
1 txn
Insider
PHILIP EDWARD M
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Class A common stock, $0.0001 par value per share F1 | 30,913 | $0.00 | $0.00 |
Holdings After Transaction:
Class A common stock, $0.0001 par value per share — 265,078 shares (Direct)
Footnotes (1)
- F1. Represents a grant of Restricted Stock Units ("RSUs"), which will be settled in shares of the Issuer's common stock upon vesting. 100% of the RSUs will become vested on the date of the Issuer's 2027 Annual Meeting of Stockholders.
Key Figures
RSUs granted: 30913.0000 shares
Shares owned after transaction: 265078.0000 shares
Grant price per share: 0.0000
+2 more
5 metrics
RSUs granted
30913.0000 shares
Grant of Restricted Stock Units to director on 2026-07-30
Shares owned after transaction
265078.0000 shares
Total direct holdings of Class A common stock following the grant
Grant price per share
0.0000
Stated price per share for the RSU award
Vesting percentage
100%
Portion of RSUs that vest on the 2027 Annual Meeting date
Transaction date
2026-07-30
Date the RSU grant to the director was made
Key Terms
Restricted Stock Units, Annual Meeting of Stockholders, beneficially owns
3 terms
Restricted Stock Units financial
"Represents a grant of Restricted Stock Units ("RSUs"), which will be settled"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Annual Meeting of Stockholders financial
"100% of the RSUs will become vested on the date of the Issuer's 2027 Annual Meeting"
beneficially owns financial
"total_shares_following_transaction": "265078.0000""
Beneficially owns means a person or entity enjoys the economic benefits and control of a security even if the legal title or registration is held in another name. Think of it like having the keys and profits from a car that is registered to a friend: you use it, benefit from it, and make decisions about it even though the official paperwork lists someone else. For investors, this matters because it reveals who truly controls shares, affects voting power, potential conflicts of interest, and regulatory disclosure obligations.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What insider transaction did SRTA director Philip Edward M report?
Director Philip Edward M reported a grant of 30,913 Restricted Stock Units, settled in Class A common stock. The award was received at a stated price of $0.00 per share as an equity compensation grant, not an open-market purchase.
When do the newly granted SRTA RSUs to Philip Edward M vest?
The 30,913 RSUs granted to Philip Edward M will become 100% vested on the date of Strata Critical Medical, Inc.’s 2027 Annual Meeting of Stockholders, at which time they will be settled in shares of common stock.
Was the SRTA RSU grant to Philip Edward M made under a Rule 10b5-1 trading plan?
The transaction is reported as a grant or award of RSUs and is not indicated as being made under a Rule 10b5-1 trading plan. It represents equity compensation rather than automatic trades under a pre-arranged plan.
What type of security was granted to Philip Edward M by SRTA?
Philip Edward M received Restricted Stock Units (RSUs) that will be settled in shares of Strata Critical Medical, Inc. Class A common stock upon vesting. The award covers 30,913 underlying shares at a stated price of $0.00 per share.